Axon Partners Group Investment, SGEIC, SA

European venture capital fund investing in innovative, growth-stage companies supplying energy transition and climate infrastructure, principally in Latin America. Its prospectus focuses on scalable, commercially established technology businesses serving consumers and companies, and permits equity and quasi-equity investments and parallel co-investment. It was registered on 10 July 2026. Its EUR275m figure is a fundraising target rather than a verified subscribed amount; final fund size and first-close date remain unverified.

Separate corporate-form European venture capital investment vehicle managed by Axon Partners Group Investment. It invests equity and quasi-equity in scalable, technology-enabled companies and may co-invest alongside parallel vehicles. The company was formed in 2025 and registered on 21 November 2025. Axon’s audited annual report groups its first close with Growth II in the second half of 2025. A standalone subscribed amount is not verified; incorporation share capital and combined strategy targets are not its closed fund size.

Growth capital fund backing established, scalable technology SMEs, especially in Spain and Italy, through minority equity positions. It was publicly announced in October 2024 and registered on 7 February 2025. The audited 2025 annual report identifies its first close as 8 September 2025; additional commitments of EUR38,030,504 signed in early 2026 are incremental commitments, not the total fund size. The original EUR200m target and EUR250m cap were later superseded by a reported EUR300m hard cap. SETT’s authorised EUR85m commitment is an LP commitment, not a final fund close. The final subscribed fund size is unverified.

Regional investment vehicle managed by Axon Partners Group Investment and registered on 9 February 2024. It supports economically viable innovation, R&D and digitalisation projects in Andalucía through minority equity stakes and debt instruments, with private co-investment. Areas include biotechnology, robotics, AI, cybersecurity, new materials and health technology. Axon publishes a EUR40m programme allocation backed by an EIB/Andalusian-government ERDF holding fund; its annual report describes EIB participation through a contingent loan. That public financing structure is distinct from a conventional private LP fundraising close, so no subscribed fund amount is asserted.